Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Theranostics|November 8, 2019
Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapySeungho Lim, Jooho Park, Man Kyu Shim, et al.
Theranostics|September 23, 2024
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugsHochung Jang, Jiwoong Choi, Daeho Park, et al.
European Journal of Pharmacology|July 24, 2017
Piperlongumine inhibits TGF-β-induced epithelial-to-mesenchymal transition by modulating the expression of E-cadherin, Snail1, and Twist1Min-Ju Park, Da-Eun Lee, Man Kyu Shim, et al.
Biomaterials|September 5, 2020
Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapyMan Kyu Shim, Yujeong Moon, Suah Yang, et al.
ACS Nano|February 28, 2025
Exosome-Inspired Lipid Nanoparticles for Enhanced Tissue PenetrationSeunghwan Bang, Byeongmin Park, Jae Chul Park, et al.
Journal of Nanobiotechnology|October 4, 2022
Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicityMan Kyu Shim, Suah Yang, Jooho Park, et al.
Acta Pharmaceutica Sinica. B|March 15, 2024
Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapyYoungjoo Lee, Sukyung Song, Suah Yang, et al.
Biomaterials|October 25, 2021
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosisJinseong Kim, Man Kyu Shim, Young-Jae Cho, et al.
Scientific Reports|December 2, 2017
Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor ApoptosisMan Kyu Shim, Hong Yeol Yoon, Sangmin Lee, et al.
ACS Nano|February 5, 2025
Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer TherapyWonbeom Park, Jiwoong Choi, Jaehyeon Hwang, et al.
Pageof 7